Details for New Drug Application (NDA): 008592
✉ Email this page to a colleague
NDA 008592 describes RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN, which is a drug marketed by Eastman Kodak and is included in one NDA. Additional details are available on the RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN profile page.
The generic ingredient in RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN is levonordefrin; procaine hydrochloride; propoxycaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; procaine hydrochloride; propoxycaine hydrochloride profile page.
The generic ingredient in RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN is levonordefrin; procaine hydrochloride; propoxycaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; procaine hydrochloride; propoxycaine hydrochloride profile page.
Summary for 008592
| Tradename: | RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN |
| Applicant: | Eastman Kodak |
| Ingredient: | levonordefrin; procaine hydrochloride; propoxycaine hydrochloride |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.033MG BASE/ML;2%;0.4% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.05MG/ML;2%;0.4% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
